Exosome Characterization and Analytical Development Summit
Evvnt Promotion / evvnt
Archiv
23.04.2024 - 25.04.2024 The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 9:00 AM - 4:45 PM
Kongressthemen
In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera's FDA IND approval to Brexogen's recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.
In the ever-evolving exosome field, the past year has witnessed remarkable progress. From Kimera's FDA IND approval to Brexogen's recent deal with HK inno.N and advancements in analytical technology, the landscape is rapidly advancing. Developing robust techniques is increasingly crucial, serving as the cornerstone for exosome therapeutics, alongside drug delivery applications and advancements.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2172701-3?pid=4832
Speakers: Brittany Mihelich, Principal Scientist, Astellas, Bruce Werber, Chief Executive Officer, BioXTek, Carla Mazzeo, Director of Research Development, AT Venture Center, and more
URL:
Brochure: https://go.evvnt.com/2172701-3?pid=4832
Speakers: Brittany Mihelich, Principal Scientist, Astellas, Bruce Werber, Chief Executive Officer, BioXTek, Carla Mazzeo, Director of Research Development, AT Venture Center, and more
Anfragen und Anmeldung:
https://go.evvnt.com/2172701-2?pid=4832
Frau Jasmine Fletcher
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
